Welcome
Welcome to CT3N
The Center's mission is to facilitate research in drug delivery and nanomedicine. We do this via our annual symposium, monthly seminar series, grants, and other activities that bring together our dozens of member faculty from Penn, CHOP, and surrounding institutions.
2026 CT3N Symposium
December 2, 2026
"Half-a-Century of Drug Delivery -
A Celebration of the Career of Vlad Muzykantov"
Missed the 2025 CT3N Symposium?
View the recordings
Upcoming Events
CT3N Faculty Publication Highlights
Shuvaev et al., PNAS (2025)

Papp et al., Molec. Therapy (2025)

Faculty in the News
A One-Two Punch: Using Lipid Nanoparticles to Transform Oral Cancer Treatment (Mike Mitchell)
Monday, July 27, 2026
Penn Engineering Awards New Scholarly Professorship (Mike Mitchell)
Wednesday, July 8, 2026
Penn Engineers Study Asthma on Human Lung-on-a-Chip Technology (Dan Huh)
Monday, June 22, 2026
AI uncovers potential antibiotics hidden in proteins linked to fatal brain disease (César de la Fuente)
Monday, June 22, 2026
Novel plant-based approach to a better, cheaper GLP-1 delivery system (Henry Daniell)
Tuesday, March 3, 2026
Featured Faculty

Claudia Loebel, MD, PhD, Assistant Professor, Department of Bioengineering, School of Engineering and Applied Science
Dr. Claudia Loebel is an Assistant Professor in the Department of Bioengineering and a core faculty member of the Penn Center for Precision Engineering for Health. She earned her medical degree from Martin Luther University Halle-Wittenberg in Germany and completed her Ph.D. at ETH Zürich, followed by postdoctoral training in the laboratory of Dr. Jason Burdick at the University of Pennsylvania. Dr. Loebel launched her independent research group at the University of Michigan in 2021 before joining the University of Pennsylvania in January 2025. Her research focuses on understanding how cells build, sense, and remodel their surrounding extracellular matrix, with a particular interest in how these dynamic matrix interactions regulate cell fate, tissue repair, and fibrosis in the lung. The Loebel lab develops engineered biomaterials, bioorthogonal labeling strategies, ex vivo tissue models, and in vivo models to study nascent extracellular matrix formation and mechanobiology in health and disease. Through this work, the lab aims to uncover how early changes in the extracellular matrix contribute to lung dysfunction and to develop new strategies to guide regeneration and prevent fibrosis.